Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01737099 · ClinicalTrials.gov registry record · NA
Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia
A NA study, sponsored by dsm-firmenich Switzerland.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT01737099: Completed NA study, sponsored by dsm-firmenich Switzerland.
NCT01737099 is a NA study that has completed, run by dsm-firmenich Switzerland. The registered enrollment target is 93 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01737099, a NA study, has completed, sponsored by dsm-firmenich Switzerland.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the efficacy and safety of DHA-O to lower elevated triglyceride levels in healthy adults with hypertriglyceridemia.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Fish oil
- DIETARY_SUPPLEMENT DHA-O
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT01737099 record still lists
NCT01737099 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01737099 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01737099 about?
NCT01737099 is a clinical study titled "Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia". The purpose of this study is to investigate the efficacy and safety of DHA-O to lower elevated triglyceride levels in healthy adults with hypertriglyceridemia.
What is the current status of trial NCT01737099?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2012-11. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01737099?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Fish oil (DIETARY_SUPPLEMENT), DHA-O (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01737099?
This trial is sponsored by dsm-firmenich Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01737099's enrollment target sits among peer trials
93 937th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia